Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Gross Margin (2016 - 2025)

Historic Gross Margin for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to 48.51%.

  • Standard Biotools' Gross Margin fell 64000.0% to 48.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.6%, marking a year-over-year decrease of 31500.0%. This contributed to the annual value of 48.31% for FY2024, which is 8600.0% up from last year.
  • As of Q3 2025, Standard Biotools' Gross Margin stood at 48.51%, which was down 64000.0% from 48.84% recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Gross Margin registered a high of 64.44% during Q1 2021, and its lowest value of 23.58% during Q2 2022.
  • In the last 5 years, Standard Biotools' Gross Margin had a median value of 48.84% in 2025 and averaged 48.76%.
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -3549800bps in 2021, then soared by 255900bps in 2023.
  • Quarter analysis of 5 years shows Standard Biotools' Gross Margin stood at 59.24% in 2021, then crashed by -30bps to 41.33% in 2022, then increased by 15bps to 47.39% in 2023, then dropped by -1bps to 46.89% in 2024, then increased by 3bps to 48.51% in 2025.
  • Its Gross Margin stands at 48.51% for Q3 2025, versus 48.84% for Q2 2025 and 48.39% for Q1 2025.